1. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J. 1992; 281(Pt 1):21–40.
2. Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM. Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J Magn Reson Imaging. 1999; 9:711–716.
3. Wang Y, Li SJ. Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 1998; 39:28–33.
4. Tan J, Bluml S, Hoang T, Dubowitz D, Mevenkamp G, Ross B. Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain. Magn Reson Med. 1998; 39:1005–1010.
5. Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res. 2003; 28:941–953.
6. Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev. 1989; 13:23–31.
7. Clark JB. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci. 1998; 20:271–276.
8. Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry. 2003; 8:721–737.
9. Oz G, Terpstra M, Tkac I, et al. Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magn Reson Med. 2006; 55:296–301.
10. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A. 2003; 100:10158–10163.
11. Nelson SJ, Kurhanewicz J, Vigneron DB, et al. Metabolic imaging of patients with prostate cancer using hyperpolarized [1-(1)(3)C]pyruvate. Sci Transl Med. 2013; 5:198ra108.
12. Park I, Larson PE, Tropp JL, et al. Dynamic hyperpolarized carbon-13 MR metabolic imaging of nonhuman primate brain. Magn Reson Med. 2014; 71:19–25.
13. Lau AZ, Miller JJ, Robson MD, Tyler DJ. Cardiac perfusion imaging using hyperpolarized (13) c urea using flow sensitizing gradients. Magn Reson Med. 2016; 75:1474–1483.
14. Albers MJ, Bok R, Chen AP, et al. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res. 2008; 68:8607–8615.
15. Harrison C, Yang C, Jindal A, et al. Comparison of kinetic models for analysis of pyruvate-to-lactate exchange by hyperpolarized 13 C NMR. NMR Biomed. 2012; 25:1286–1294.
16. Atherton HJ, Schroeder MA, Dodd MS, et al. Validation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised 13C MRS. NMR Biomed. 2011; 24:201–208.
17. Kettunen MI, Hu DE, Witney TH, et al. Magnetization transfer measurements of exchange between hyperpolarized [1-13C] pyruvate and [1-13C]lactate in a murine lymphoma. Magn Reson Med. 2010; 63:872–880.
18. Xu T, Mayer D, Gu M, et al. Quantification of in vivo metabolic kinetics of hyperpolarized pyruvate in rat kidneys using dynamic 13C MRSI. NMR Biomed. 2011; 24:997–1005.
19. Yen YF, Le Roux P, Mayer D, et al. T(2) relaxation times of (13)C metabolites in a rat hepatocellular carcinoma model measured in vivo using (13)C-MRS of hyperpolarized [1-(13)C]pyruvate. NMR Biomed. 2010; 23:414–423.
20. Brindle KM. NMR methods for measuring enzyme kinetics in vivo. Prog NMR Spectrosc. 1988; 20:257–293.
21. McConnell HM. Reaction rates by nuclear magnetic resonance. J Chem Phys. 1958; 28:430–431.
22. Oppenheim AV, Willsky AS, Nawab SH. Signals and systems. 2nd ed. Upper Saddle River, NJ: Prentice Hall;1997. p. 957.
23. Kazan SM, Reynolds S, Kennerley A, et al. Kinetic modeling of hyperpolarized (13)C pyruvate metabolism in tumors using a measured arterial input function. Magn Reson Med. 2013; 70:943–953.
24. von Morze C, Larson PE, Hu S, et al. Imaging of blood flow using hyperpolarized [(13)C]urea in preclinical cancer models. J Magn Reson Imaging. 2011; 33:692–697.
25. Zierhut ML, Yen YF, Chen AP, et al. Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. J Magn Reson. 2010; 202:85–92.
26. Santarelli MF, Positano V, Giovannetti G, et al. How the signal-to-noise ratio influences hyperpolarized 13C dynamic MRS data fitting and parameter estimation. NMR Biomed. 2012; 25:925–934.
27. Menichetti L, Frijia F, Flori A, et al. Assessment of realtime myocardial uptake and enzymatic conversion of hyperpolarized [1-(1)(3)C]pyruvate in pigs using slice selective magnetic resonance spectroscopy. Contrast Media Mol Imaging. 2012; 7:85–94.
28. Lee H, Lee J, Joe E, et al. Determination of optimal scan time for the measurement of downstream metabolites in hyperpolarized 13C MRSI. Investig Magn Reson Imaging. 2015; 19:212–217.
29. Hill DK, Orton MR, Mariotti E, et al. Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data. PLoS One. 2013; 8:e71996.